title: Remote interstitial afterloading in cancer of the prostate: preliminary experience with the MicroSelectron.
abstract: Brachytherapy in the treatment of prostate cancer is an accepted modality. A considerable experience has been accrued using Iridium interstitial therapy. The major problem associated with this choice is that of radioprotection. We describe the first clinical use of the MicroSelectron, a remote afterloading device, in prostate brachytherapy. Twenty-six patients have now been treated using this system. Approximately 55 treatment interruptions with an average 5 hr increase in overall treatment time occurs. The initial problems associated with instituting remote afterloading to prostate brachytherapy and their solutions are discussed.
authors.affiliation: Dept. of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.
authors.forename: A T
authors.initials: AT
authors.lastname: Porter
authors.forename: J W
authors.initials: JW
authors.lastname: Scrimger
authors.forename: J S
authors.initials: JS
authors.lastname: Pocha
mesh_terms: D001918:Brachytherapy / Q000295:instrumentation*; D006801:Humans; D007496:Iridium Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011835:Radiation Protection / Q000295:instrumentation*
chemical_list: D007496:Iridium Radioisotopes